Log in
NASDAQ:BCPC

Balchem Stock Forecast, Price & News

$95.65
+0.36 (+0.38 %)
(As of 09/28/2020 12:49 AM ET)
Add
Compare
Today's Range
$94.97
Now: $95.65
$95.90
50-Day Range
$94.78
MA: $98.82
$103.46
52-Week Range
$78.30
Now: $95.65
$113.93
Volume61,300 shs
Average Volume138,834 shs
Market Capitalization$3.09 billion
P/E Ratio37.81
Dividend Yield0.54%
Beta0.62
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include creamer and chocolate systems, dairy replacers, powdered fats, nutritional beverage bases, beverages, juice and dairy bases, ice cream bases and variegates, cereals, grain based snacks, and cereal based ingredients. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.
Read More
Balchem logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.63 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
Current SymbolNASDAQ:BCPC
CUSIP05766520
CIK9326
Phone845-326-5600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$643.71 million
Cash Flow$4.65 per share
Book Value$23.12 per share

Profitability

Net Income$79.67 million

Miscellaneous

Employees1,424
Market Cap$3.09 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$95.65
+0.36 (+0.38 %)
(As of 09/28/2020 12:49 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BCPC News and Ratings via Email

Sign-up to receive the latest news and ratings for BCPC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Balchem (NASDAQ:BCPC) Frequently Asked Questions

How has Balchem's stock price been impacted by COVID-19 (Coronavirus)?

Balchem's stock was trading at $89.29 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, BCPC shares have increased by 7.1% and is now trading at $95.65.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Balchem?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Balchem
.

When is Balchem's next earnings date?

Balchem is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Balchem
.

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) issued its quarterly earnings data on Friday, July, 31st. The basic materials company reported $0.85 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.55 by $0.30. The basic materials company had revenue of $173.36 million for the quarter, compared to analysts' expectations of $161.35 million. Balchem had a return on equity of 14.32% and a net margin of 12.18%. The business's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.77 EPS.
View Balchem's earnings history
.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem announced an annual dividend on Wednesday, December 18th. Shareholders of record on Monday, December 30th will be given a dividend of $0.52 per share on Friday, January 17th. This represents a yield of 0.51%. The ex-dividend date of this dividend is Friday, December 27th. This is a boost from Balchem's previous annual dividend of $0.47.
View Balchem's dividend history
.

What price target have analysts set for BCPC?

2 analysts have issued 1 year price targets for Balchem's stock. Their forecasts range from $100.00 to $126.00. On average, they expect Balchem's stock price to reach $113.00 in the next year. This suggests a possible upside of 18.1% from the stock's current price.
View analysts' price targets for Balchem
.

Are investors shorting Balchem?

Balchem saw a decline in short interest in the month of August. As of August 14th, there was short interest totaling 442,800 shares, a decline of 14.3% from the July 30th total of 516,600 shares. Based on an average daily volume of 136,600 shares, the short-interest ratio is currently 3.2 days. Currently, 1.4% of the shares of the stock are sold short.
View Balchem's Short Interest
.

Who are some of Balchem's key competitors?

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

Who are Balchem's key executives?

Balchem's management team includes the following people:
  • Mr. Theodore L. Harris, Chairman and Chief Exec. Officer (Age 54)
  • Mr. William A. Backus CPA, Chief Accounting Officer (Age 53)
  • Mr. Mark A. Stach, Gen. Counsel & Corp. Sec.
  • Mr. David F. Ludwig, VP & Gen. Mang. of Industrial Products (Age 61)
  • Mr. Carl Martin Bengtsson, Chief Financial Officer

What is Balchem's stock symbol?

Balchem trades on the NASDAQ under the ticker symbol "BCPC."

Who are Balchem's major shareholders?

Balchem's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.22%), Conestoga Capital Advisors LLC (2.75%), Wasatch Advisors Inc. (2.58%), Macquarie Group Ltd. (1.79%), FMR LLC (1.26%) and Bank of New York Mellon Corp (1.16%). Company insiders that own Balchem stock include Daniel E Knutson, David F Ludwig and Scott C Mason.
View institutional ownership trends for Balchem
.

Which major investors are selling Balchem stock?

BCPC stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., New York State Common Retirement Fund, Vanguard Group Inc., ProShare Advisors LLC, Moody Aldrich Partners LLC, Stephens Investment Management Group LLC, Sei Investments Co., and Prudential Financial Inc..
View insider buying and selling activity for Balchem
.

Which major investors are buying Balchem stock?

BCPC stock was bought by a variety of institutional investors in the last quarter, including FMR LLC, Assenagon Asset Management S.A., Bank of Montreal Can, Nuveen Asset Management LLC, State of Wisconsin Investment Board, Conestoga Capital Advisors LLC, Man Group plc, and Macquarie Group Ltd.. Company insiders that have bought Balchem stock in the last two years include Daniel E Knutson, and Scott C Mason.
View insider buying and selling activity for Balchem
.

How do I buy shares of Balchem?

Shares of BCPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Balchem's stock price today?

One share of BCPC stock can currently be purchased for approximately $95.65.

How big of a company is Balchem?

Balchem has a market capitalization of $3.09 billion and generates $643.71 million in revenue each year. The basic materials company earns $79.67 million in net income (profit) each year or $3.19 on an earnings per share basis. Balchem employs 1,424 workers across the globe.

What is Balchem's official website?

The official website for Balchem is www.balchem.com.

How can I contact Balchem?

Balchem's mailing address is 52 Sunrise Park Road, NEW HAMPTON NY, 10958. The basic materials company can be reached via phone at 845-326-5600 or via email at [email protected]

This page was last updated on 9/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.